Pacific Health Care Organization Inc (PFHO) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Pacific Health Care Organization Inc (PFHO) stock forecast summary
On Oct. 14, 2026, PFHO is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.
Pacific Health Care Organization Inc is a small-cap company with a market capitalization of $12M. It ranks number 10 by market capitalization among the 11 Services-Misc Health & Allied Services, NEC issuers in our coverage with a current forecast. Its Net Margin of 15.2% is the highest of the 10 peers that report one. Its Current Ratio of 27.21x is the highest of the 11 peers that report one.
A per-ticker accuracy statistic for PFHO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, PFHO included.
Follow PFHO freePFHO price chart and AI forecast
How PFHO ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Pacific Health Care Organization Inc (PFHO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.
Valuation & Market
| Metric | PFHO | Rank |
|---|---|---|
| Market Cap | $12M | 10/11 |
| P/E Ratio | 12.16x | 5/5 |
| P/B Ratio | 0.88x | 6/7 |
| EPS | $0.09 | – |
| Book Value/Share | $1.06 | – |
| Revenue/Share | $0.50 | – |
| FCF/Share | $0.05 | – |
Profitability & Margins
| Metric | PFHO | Rank |
|---|---|---|
| ROE | 7.2% | 4/7 |
| ROA | 6.9% | 3/10 |
| ROIC | 6.8% | 5/8 |
| Operating Margin | 14.4% | 2/9 |
| Net Margin | 15.2% | 1/10 |
| EBT Margin | 20.6% | 2/10 |
| Tax Rate | 26.1% | – |
Financial Health
| Metric | PFHO | Rank |
|---|---|---|
| Current Ratio | 27.21x | 1/11 |
| D/E Ratio | 0.04x | 9/9 |
| Financial Leverage | 1.04x | 9/9 |
| Interest Coverage | 206.6x | 1/12 |
| Working Capital | $14M | 5/11 |
Cash Flow
| Metric | PFHO | Rank |
|---|---|---|
| Operating Cash Flow | $600K | 7/11 |
| Free Cash Flow | $580K | 6/7 |
| Capital Spending | -$20K | 1/7 |
| OCF Growth YoY | -50.7% | 7/7 |
| FCF Growth YoY | -51.8% | 5/5 |
| FCF/Sales | 9.0% | 6/7 |
| CapEx/Sales | 0.3% | 6/7 |
Operational Efficiency
| Metric | PFHO | Rank |
|---|---|---|
| Asset Turnover | 0.46x | 7/9 |
| Receivables Turnover | 4.8x | 8/9 |
| Fixed Assets Turnover | 142.3x | 2/8 |
| Days Sales Outstanding | 75 days | 2/9 |
Income Statement
| Metric | PFHO | Rank |
|---|---|---|
| Total Revenue | $6M | 8/9 |
| Operating Income | $0.00M | 5/10 |
| Net Income | $0.00M | 5/10 |
Dividend & Shareholder Information
| Metric | PFHO | Rank |
|---|---|---|
| Shares Outstanding | 13M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $14M | 100.0% of assets |
| Cash & Short-term Investments | $2M | 16.0% of assets |
| Accounts Receivable | $1M | 9.5% of assets |
| Total Liabilities | $520K | 3.7% of assets |
| Short-term Debt | $280K | 2.0% of assets |
PFHO quarterly financials and insider trading
Pacific Health Care Organization Inc (PFHO) industry peers
Companies classified under the same SEC industry code as Pacific Health Care Organization Inc (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| PFHO Pacific Health Care Organization Inc | ▶ | $12M |
| DVA Davita Inc. | ▶ | $11.62B |
| FMS Fresenius Medical Care Ag | ▼ | $5.89B |
| SHC Sotera Health Co | ▶ | $5.20B |
| PGNY Progyny, Inc. | ▶ | $2.10B |
| AGL Agilon Health, Inc. | ▲ | $1.44B |
| VMD Viemed Healthcare, Inc. | ▶ | $366M |
| PARK Park Dental Partners, Inc. | ▲ | $96M |
| MRAI Marpai, Inc. | ▲ | $86M |
| CCEL Cryo Cell International Inc | ▶ | $35M |
| MGRX Mangoceuticals, Inc. | ▶ | $8M |
| BRTX Biorestorative Therapies, Inc. | ▼ | N/A |
| NIVF Newgenivf Group Ltd | ▼ | N/A |
Where PFHO sits on the market map
Pacific Health Care Organization Inc (PFHO) stock news
Loading...
Pacific Health Care Organization Inc (PFHO) stock forecast FAQ
What is the Pacific Health Care Organization Inc (PFHO) stock forecast?
On Oct. 14, 2026, PFHO is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5379 stocks scored that day.
How accurate are Pacific Health Care Organization Inc stock predictions?
A per-ticker accuracy statistic for PFHO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Pacific Health Care Organization Inc forecasts updated?
Pacific Health Care Organization Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Pacific Health Care Organization Inc's industry peers?
13 issuers in our coverage, PFHO included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Davita Inc. (DVA), Fresenius Medical Care Ag (FMS), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Agilon Health, Inc. (AGL), Viemed Healthcare, Inc. (VMD).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.